LANXESS reported a challenging Q3, reflecting a significant decline in sales and EBITDA due to weak demand across key segments, notably affected by external economic pressures and competitive dynamics.

• Sales dropped 16% year-over-year, driven by unfavorable currency impacts and a 6% decline in volumes.
• EBITDA is expected to align with the lower end of guidance at €520 million to €580 million.
• The consumer protection segment remained stable with a margin just under 16%, contrasting sharply with struggles in other sectors.
• Strong competition from Chinese producers and high energy costs continue to plague the Advanced Intermediates and Specialty Additives segments.
• Ongoing cost control measures are in place, with anticipated structural improvements of around CHF 100 million being discussed for the coming years.